Representation disparity in ages below and above 75 years

Singapore - In the first comprehensive analysis of clinical trial enrolment among older adults with blood cancers, resea...

December 12, 2017 | Tuesday | News
Juno Therapeutics signs three license agreements

US based biopharma company Juno Therapeutics has announced three license agreements to advance its program in multiple m...

December 11, 2017 | Monday | News
FDA approves Amgen's Repatha (evolocumab)

Amgen has announced that following priority review of its supplemental Biologics License Application, the U.S. Food...

December 7, 2017 | Thursday | News
Mr. Jeong Woo Choo has been appointed as the President and CEO of SK Biopharmaceuticals and SK Life Science

Jeong Woo Cho, Ph.D., has been appointed president and CEO of SK biopharmaceuticals and SK life science to lead the comp...

December 1, 2017 | Friday | News
Janssen supports first-of-its-kind Asia Pacific Prostate Cancer- Patient Coalition to improve patient outcomes across the region

Singapore – Janssen Asia Pacific announced it has supported the establishment of the first-of-its-kind Asia Pacifi...

November 30, 2017 | Thursday | News
Biohaven receives agreement from FDA on initial pediatric study plan

Biohaven Pharmaceutical Holding Company Ltd. has announced that the Company has received agreement from the U.S. Food an...

November 28, 2017 | Tuesday | News
Biogen and Alkermes announce license and collaboration agreement

US based biotech company Biogen and pharma company Alkermes  has announced that they have entered into a global lic...

November 28, 2017 | Tuesday | News
GSK submits landmark IMPACT data to USFDA for the use of Trelegy Ellipta

Pharma company, GlaxoSmithKline and Innoviva has announced the filing of a supplemental New Drug Application (sNDA) with...

November 27, 2017 | Monday | News
Puma biotech and Specialised Therapeutics signs agreement to commercialize NERLYNX®

Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX&r...

November 24, 2017 | Friday | News
Step Pharma completes €14.5 million Series A financing

France based Step Pharma has announced the closing of a Series A financing totalling €14.5 million. Pontifax will ...

November 23, 2017 | Thursday | News
FDA approves RxSight's light adjustable lens

Singapore – RxSight (a US based medical devices company) announced that the U.S. Food and Drug Administration (FDA...

November 23, 2017 | Thursday | News
PeptiDream announces collaboration with Bayer

Japan based biopharma company PeptiDream Inc. has announced that it has entered into a multi-target discovery collaborat...

November 21, 2017 | Tuesday | News
Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen

U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Gener...

November 17, 2017 | Friday | News
Cue Biopharma announces research collaboration with Merck

US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and licens...

November 17, 2017 | Friday | News
Generic Acticlate tablets launched by Lupin in USA

Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from ...

November 6, 2017 | Monday | News
Lupin net profit falls 31% in Q2 to Rs 455

Pharma company Lupin reported its financial performance for the second quarter ending September 30th, 2017. The company...

October 31, 2017 | Tuesday | News
Lupin receives FDA approval for generic Axiron topical solution

Pharma Major Lupin has received final approval for its Testosterone Topical Solution, 30 mg per actuation from the Unite...

October 27, 2017 | Friday | News
Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets

Pharma Major Lupin has announced that it has received final approval for its Carbidopa Tablets, 25 mg and Clonidine Hydr...

October 27, 2017 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls